ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors with Losses in Excess of $100k to Secure Counsel Before Important April 9 Deadline in Securities Class Action - AMLX
- Written by Reporters
New York, New York - Newsfile Corp. - March 28, 2024 - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) between November 11, 2022 and November 8, 2023, both dates inclusive (the "Class Period"), of the important April 9, 2024 lead plaintiff deadline.SO WHAT: If...